Patent · US Active

Methods of using diaminopyrimidine P2X3 and P2X2/3 receptor modulators for treatment of respiratory and gastrointestinal diseases

US8008313B2 · kind B2 · utility

6Cited by
1References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 25, 2006
Grant dateAug 30, 2011
Priority date
Expiry dateOct 2, 2029

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods for treating respiratory and gastrointestinal diseases mediated by a P2X3 and/or a P2X2/3 receptor antagonist, the methods comprising administering to a subject in need thereof an effective amount of a compound of formula (I):or a pharmaceutically acceptable salt thereof,

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.